Medrio
Medrio provides cloud-based electronic data capture (EDC) and eClinical software used to design, run, and manage clinical trials for biopharma, medical device, and contract research organizations, with a focus on decentralized and hybrid studies. Its platform supports study build, data collection, eConsent, and patient engagement, and it generates revenue through subscription licensing and related professional services.
- Clinical Trial & Research Software
- Revenue
- $55.0M
- Employees
- 350
- Founded
- 2005
- Headquarters
- San Francisco, United States of America
What 27 Arbolus experts think of Medrio
NPS responses range from 4 to 10, with a mean NPS in the mid-7s and a notable cluster of highly positive (9–10) responses among high-spend, long-tenured users. Renewal intent is strong in accounts with more than 1 year of implementation and significant spend, while pilot-phase and smaller users show greater uncertainty. Sentiment drivers include ease of use, regulatory compliance, and customer support, with negative feedback focused on reporting flexibility and pilot user satisfaction. Overall Customer Sentiment: Positive
Who reviewed Medrio
- C-Suite 52% (14)
- Director 37% (10)
- Manager 11% (3)
Employer names and spend open in the full report, along with the other 24 customers.
Everything 27 customers told us about Medrio.
Employer names, spend, renewal intent and every written answer behind the numbers on this page.
Sentiment
11 Net Promoter Score, from 27 scored reviews- Promoters 9
- Passives 12
- Detractors 6
Cumulative NPS by month
+0 over 6 months- Feb 8
- Apr 7
- May 8
- Jun 8
- Aug 8
- Sep 8
Net Promoter Score across 4 reviews, accumulated up to each month. Category median 26 across 4 companies.
Praised
- Improved Reporting
- Enterprise Upsell from Pilots
- AI-Driven Optimization
- Customer Support
Criticised
- Pilot User Preference for Alternatives
- Limited Reporting Flexibility
- Non-Critical for Advanced Trials
- Reliance on Rave EDC
What customers say
Renewal intent
Plan to renew 68%Plan to renew, by seniority
- 75% 12 answers
- 40% 5 answers
- 100% 2 answers
- 8.8/10 Average score from customers who will renew
- 6.4/10 Average score from undecided customers
- 7/10 Average score from customers not renewing
Top alternatives
Most weighed by Medrio customersReport
For people who use Medrio
Do you use Medrio at work?
Share your software review and get matched to paid projects. Arbolus pays you every time a client reads your review.
- 27 customers of Medrio have already contributed
Takes a few minutes. Your identity stays anonymous.